Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Stoddard

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Human Vaccines|December 17, 2009
Universal immunization of infants against Neisseria meningitidis: addressing the remaining unmet medical need in the prevention of meningitis and septicemiaJeffrey Stoddard, Nancy Dougherty
Expert Review of Vaccines|December 18, 2010
Menveo®): a novel quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135 and YBrian Cooper, Lisa DeTora, Jeffrey Stoddard
Respiratory Medicine|November 6, 2004
Antibiotic prescribing rates in the US ambulatory care setting for patients diagnosed with influenza, 1997-2001Gabrielle Ciesla, Shelah Leader, Jeffrey Stoddard
Immunotherapy|May 13, 2014
Use of a multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) for bacterial meningitis preventionSusanna Esposito, Luca Castellazzi, Annalisa Bosco, et al.
Drugs|December 17, 2013
A multi-component meningococcal serogroup B vaccine (4CMenB): the clinical development programMiguel O'Ryan, Jeffrey Stoddard, Daniela Toneatto, et al.
Journal of Managed Care & Specialty Pharmacy|August 27, 2015
Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital DischargeSteven C Marcus, Jacqueline Zummo, Amy R Pettit, et al.
Expert Review of Vaccines|December 21, 2004
Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccineRobert Belshe, Min-Shi Lee, Robert E Walker, et al.
Vaccine|December 22, 2021
Clinical and economic outcomes associated with respiratory syncytial virus vaccination in older adults in the United StatesWilliam L Herring, Yuanhui Zhang, Vivek Shinde, et al.
Plos One|August 11, 2017
The epidemiology of medically attended respiratory syncytial virus in older adults in the United States: A systematic reviewAnn D Colosia, Jin Yang, Eric Hillson, et al.
Human Vaccines & Immunotherapeutics|April 1, 2022
Burden of opioid use for pain management among adult herpes zoster patients in the US and the potential impact of vaccinationJean-Etienne Poirrier, Jessica K DeMartino, Saurabh Nagar, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Human Vaccines|December 17, 2009
Universal immunization of infants against Neisseria meningitidis: addressing the remaining unmet medical need in the prevention of meningitis and septicemiaJeffrey Stoddard, Nancy Dougherty
Expert Review of Vaccines|December 18, 2010
Menveo®): a novel quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135 and YBrian Cooper, Lisa DeTora, Jeffrey Stoddard
Respiratory Medicine|November 6, 2004
Antibiotic prescribing rates in the US ambulatory care setting for patients diagnosed with influenza, 1997-2001Gabrielle Ciesla, Shelah Leader, Jeffrey Stoddard
Immunotherapy|May 13, 2014
Use of a multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) for bacterial meningitis preventionSusanna Esposito, Luca Castellazzi, Annalisa Bosco, et al.
Drugs|December 17, 2013
A multi-component meningococcal serogroup B vaccine (4CMenB): the clinical development programMiguel O'Ryan, Jeffrey Stoddard, Daniela Toneatto, et al.
Journal of Managed Care & Specialty Pharmacy|August 27, 2015
Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital DischargeSteven C Marcus, Jacqueline Zummo, Amy R Pettit, et al.
Expert Review of Vaccines|December 21, 2004
Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccineRobert Belshe, Min-Shi Lee, Robert E Walker, et al.
Vaccine|December 22, 2021
Clinical and economic outcomes associated with respiratory syncytial virus vaccination in older adults in the United StatesWilliam L Herring, Yuanhui Zhang, Vivek Shinde, et al.
Plos One|August 11, 2017
The epidemiology of medically attended respiratory syncytial virus in older adults in the United States: A systematic reviewAnn D Colosia, Jin Yang, Eric Hillson, et al.
Human Vaccines & Immunotherapeutics|April 1, 2022
Burden of opioid use for pain management among adult herpes zoster patients in the US and the potential impact of vaccinationJean-Etienne Poirrier, Jessica K DeMartino, Saurabh Nagar, et al.
Pageof 2